Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
5
NMPA:5
Drug Approvals
Diquafosol Sodium Eye Drops
- Product Name
- 地夸磷索钠滴眼液
- Approval Number
- 国药准字H20254149
- Approval Date
- May 13, 2025
NMPA
Recombinant Human Epidermal Growth Factor Derivative For External Use, Liquid
- Product Name
- 人表皮生长因子外用溶液(Ⅰ)
- Approval Number
- 国药准字S20010037
- Approval Date
- Apr 8, 2020
NMPA
Recombinant Human Epidermal Growth Factor Derivative For External Use, Liquid
- Product Name
- 人表皮生长因子外用溶液(Ⅰ)
- Approval Number
- 国药准字S20010038
- Approval Date
- Apr 8, 2020
NMPA
Human Epidermal Growth Factor （ARI Extended Type）Eye Drops
- Product Name
- 金因舒
- Approval Number
- 国药准字S20040006
- Approval Date
- Mar 11, 2020
NMPA
Clinical Trials
No trials found
News
No news found